Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Antibiotic therapy may prevent the development of infection in patients with
hematologic cancer and the persistent fever caused by a low white blood cell count. It is not
yet known which regimen of antibiotics is most effective in preventing infection in these
patients.
PURPOSE: Randomized phase III trial to study the effectiveness of piperacillin-tazobactam
with or without vancomycin in reducing fever in patients who have leukemia, lymphoma, or
Hodgkin's disease.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Treatments:
Penicillanic Acid Piperacillin Piperacillin, Tazobactam Drug Combination Tazobactam Vancomycin